Daigo Miyazaki

Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers

Daigo Miyazaki, Akinori Nakamura, Kazuhiro Fukushima et al. · Human Molecular Genetics · 2011 · 80 citations · Full text

Comparison of the phenotypes of patients harboring in-frame deletions starting at exon 45 in the Duchenne muscular dystrophy gene indicates potential for the development of exon skipping therapy

Akinori Nakamura, Naoko Shiba, Daigo Miyazaki et al. · Journal of Human Genetics · 2016 · 69 citations

Mendelian Disorder, Genetic Disorder, Genetics +6

Deletion of exons 3−9 encompassing a mutational hot spot in the DMD gene presents an asymptomatic phenotype, indicating a target region for multiexon skipping therapy

Akinori Nakamura, Noboru Fueki, Naoko Shiba et al. · Journal of Human Genetics · 2016 · 66 citations

Transcriptional Regulation, Systems Biology, Engineering +11

GCH1 mutations in dopa-responsive dystonia and Parkinson’s disease

Hiroyo Yoshino, Kenya Nishioka, Yuanzhe Li et al. · Journal of Neurology · 2018 · 48 citations

Neurodegenerative Diseases, Molecular Neuroscience, Parkinson Disease +8

Spinocerebellar ataxia type 6 (SCA6): Clinical pilot trial with gabapentin

Katsuya Nakamura, Kunihiro Yoshida, Daigo Miyazaki et al. · Journal of the Neurological Sciences · 2009 · 35 citations

Neurobiology Of Disease, Neurological Disorder, Clinical Neurology +7